{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T06:53:43Z","timestamp":1770965623162,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1016\/j.ijantimicag.2008.12.010","type":"journal-article","created":{"date-parts":[[2009,2,24]],"date-time":"2009-02-24T11:43:11Z","timestamp":1235475791000},"page":"564-568","source":"Crossref","is-referenced-by-count":53,"title":["Characterisation of a Staphylococcus aureus strain with progressive loss of susceptibility to vancomycin and daptomycin during therapy"],"prefix":"10.1016","volume":"33","author":[{"given":"Fred C.","family":"Tenover","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott W.","family":"Sinner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert E.","family":"Segal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanthida","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shandline S.","family":"Alexandre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"John E.","family":"McGowan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melvin P.","family":"Weinstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2008.12.010_bib1","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1086\/513203","article-title":"The rationale for revising the Clinical and Laboratory Standards Institute vancomycin minimal inhibitory concentration interpretive criteria for Staphylococcus aureus","volume":"44","author":"Tenover","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2008.12.010_bib2","unstructured":"Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard. 7th ed. Document M7-A7. Wayne, PA: CLSI; 2006."},{"key":"10.1016\/j.ijantimicag.2008.12.010_bib3","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1128\/JCM.01508-06","article-title":"A multicenter study evaluating the current strategies for isolating Staphylococcus aureus strains with reduced susceptibility to glycopeptides","volume":"45","author":"Wootton","year":"2007","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2008.12.010_bib4","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/jac\/45.1.130","article-title":"Heterogeneous resistance to vancomycin in Staphylococcus aureus","volume":"45","author":"Howe","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2008.12.010_bib5","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1086\/381202","article-title":"Treatment outcomes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility","volume":"38","author":"Howden","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2008.12.010_bib6","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2174\/1568005043340470","article-title":"The escalating challenge of vancomycin resistance in Staphylococcus aureus","volume":"4","author":"Pfeltz","year":"2004","journal-title":"Curr Drug Targets Infect Disord"},{"key":"10.1016\/j.ijantimicag.2008.12.010_bib7","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(97)07324-8","article-title":"Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin","volume":"350","author":"Hiramatsu","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2008.12.010_bib8","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.ijantimicag.2006.07.020","article-title":"The need for accuracy in performing vancomycin intermediate resistant Staphylococcus aureus (VISA) and hetero-VISA detection methods","volume":"28","author":"Wootton","year":"2006","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2008.12.010_bib9","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1093\/jac\/47.4.399","article-title":"A modified population analysis profile (PAP) method to detect hetero-resistance to vancomycin in Staphylococcus aureus in a UK hospital","volume":"47","author":"Wootton","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2008.12.010_bib10","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1128\/JCM.39.7.2439-2444.2001","article-title":"Evaluation of current methods for detection of staphylococci with reduced susceptibility to glycopeptides","volume":"39","author":"Walsh","year":"2001","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2008.12.010_bib11","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/jac\/42.2.199","article-title":"Activated cell-wall synthesis is associated with vancomycin resistance in methicillin-resistant Staphylococcus aureus clinical strains Mu3 and Mu50","volume":"42","author":"Hanaki","year":"1998","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2008.12.010_bib12","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1128\/JCM.00265-08","article-title":"Evaluation of a new Etest vancomycin\u2013teicoplanin strip for detection of glycopeptide-intermediate Staphylococcus aureus (GISA), in particular, heterogeneous GISA","volume":"46","author":"Yusof","year":"2008","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2008.12.010_bib13","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1128\/AAC.50.3.1079-1082.2006","article-title":"Correlation between reduced daptomycin susceptibility and vancomycin resistance in vancomycin-intermediate Staphylococcus aureus","volume":"50","author":"Cui","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2008.12.010_bib14","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1128\/AAC.50.4.1581-1585.2006","article-title":"Induction of daptomycin heterogeneous susceptibility in Staphylococcus aureus by exposure to vancomycin","volume":"50","author":"Sakoulas","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2008.12.010_bib15","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1128\/AAC.00039-06","article-title":"Genetic changes that correlate with reduced susceptibility to daptomycin in Staphylococcus aureus","volume":"50","author":"Friedman","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2008.12.010_bib16","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1128\/AAC.00559-07","article-title":"Characterization of a daptomycin-nonsusceptible vancomycin-intermediate Staphylococcus aureus strain in a patient with endocarditis","volume":"51","author":"Julian","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2008.12.010_bib17","doi-asserted-by":"crossref","first-page":"5113","DOI":"10.1128\/JCM.41.11.5113-5120.2003","article-title":"Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database","volume":"41","author":"McDougal","year":"2003","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2008.12.010_bib18","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1128\/AAC.44.2.294-303.2000","article-title":"Characterization of passage-selected vancomycin-resistant Staphylococcus aureus strains of diverse parental backgrounds","volume":"44","author":"Pfeltz","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2008.12.010_bib19","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1046\/j.1469-0691.2003.00734.x","article-title":"Vancomycin-resistant Staphylococcus aureus: no apocalypse now","volume":"9","author":"Goldstein","year":"2003","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2008.12.010_bib20","doi-asserted-by":"crossref","first-page":"4207","DOI":"10.1128\/AAC.00676-08","article-title":"Improved antimicrobial activity of linezolid against vancomycin-intermediate Staphylococcus aureus","volume":"52","author":"Watanabe","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2008.12.010_bib21","doi-asserted-by":"crossref","first-page":"4289","DOI":"10.1128\/AAC.00417-08","article-title":"Serial daptomycin selection generates daptomycin-nonsusceptible Staphylococcus aureus strains with a heterogeneous vancomycin-intermediate phenotype","volume":"52","author":"Camargo","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2008.12.010_bib22","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1089\/107662903322762833","article-title":"In vitro activities of daptomycin, linezolid, and quinupristin\u2013dalfopristin against a challenge panel of staphylococci and enterococci, including vancomycin-intermediate S. aureus and vancomycin-resistant E. faecium","volume":"9","author":"Jevitt","year":"2003","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.ijantimicag.2008.12.010_bib23","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1086\/504084","article-title":"An association between reduced susceptibility to daptomycin and reduced susceptibility to vancomycin in Staphylococcus aureus","volume":"42","author":"Patel","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2008.12.010_bib24","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1056\/NEJMoa053783","article-title":"Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus","volume":"355","author":"Fowler","year":"2006","journal-title":"N Engl J Med"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857909000211?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857909000211?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,21]],"date-time":"2018-12-21T07:56:56Z","timestamp":1545379016000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857909000211"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["S0924857909000211"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2008.12.010","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}